Background/Aims: Unexpected transmissions of viral pathogens during solid organ transplantation (SOT) can result in severe, life-threatening diseases in transplant recipients. Immune activation contributes to disease onset. However mechanisms balancing the immune response against transmitted viral infection through organ transplantation remain unknown.
IL-10 Induces T Cell Exhaustion During Transplantation of Virus Infected Hearts
The main reason for graft rejection is viral infection during heart transplantation. 40% of the heart rejections in humans are associated with infections [4, 5] . Those infections are mainly herpes viruses. Considering viral infection in transplantation, we distinguish between reactivation of previous infections in donor or recipient and unexpected transmission of viral infections through organ transplantation which is defined as donor-derived viral infection. Even though, transmission of acute or latent infection to organ transplant recipient is approximately 0.2% of transplantation; once it occurs, it leads to significantly increased morbidity and mortality in recipients [6] . Expected viral infections detected by serological analysis in transplantation medicine are known for cytomegalovirus (CMV), Epstein-Barr virus (EBV) and hepatitis B virus (HBV) [7] . Special prophylaxis and infection management are preserved in this setting.
Of greater concern are unexpected viral infections transmitted via donor organs. Several reports of infectious diseases through SOT are published and estimated number of unreported cases has to be considered. Donor-derived viral infections include a growing number of pathogens such as hepatitis B and C, herpes viruses, human T-cell lymphotropic viruses (HTLV) 1 and 2, West Nile virus, Rabies, LCMV, polyomavirus, parvovirus B19 and many other viruses [8, 9] . In most of such transmissions the mortality is high [10] .
Detection of infectious disease in transplant donors is limited by technical means and by the short time period between death of donor and the use of donor organs. So, routinely evaluation of donors for infectious disease is determined by antibody detection. Nevertheless, a window of false negative detection for infectious disease exists. For example, the window for hepatitis C virus (HCV) to seroconversion is 30 to 70 days. Improvements have been done by nucleic acid testing (NAT), so that the time period could be reduced. But still, some infections remain undetected [11, 12] .
T cells have emerged as a major threat in acute rejection after SOT [13] . Whether naïve or memory T cells get activated by transfer of viral infected hearts remains unclear. Further analysis has to be done in the field of transplantation medicine to understand the activation of immune cells by this route of infection. Mechanisms leading to exhaustion of T cells and in consequence to tolerance in transplantation medicine have to be investigated.
Here we transplanted hearts from LCMV carrier mice into naïve or memory C57BL/6 mice and analyzed proliferation of CD8 + T cells, viral clearance and syngeneic graft survival. We found that syngeneic heart transplantation (HTX) of LCMV carrier heart led to viral persistence in wild type (WT) mice, but also to syngeneic graft survival. Viral persistence and syngeneic graft survival in WT mice were due to IL-10 induced T cell exhaustion. In case of memory mice as recipient, IL-10 was not able to exhaust memory CD8 + T cells and virus could be controlled leading to syngeneic graft rejection. Transplantation of LCMV carrier heart in IL-10 deficient mice caused death due to immunopathology.
Materials and Methods

Heterotopic Cardiac Transplantation
Syngeneic heart transplant was vascularly anastomosed in an intraabdominal location using the technique described by Corry et al. [14, 15] as modified by Nagano et al. [16] . Graft ischemic time was typically 20 -25 min and total operative time was 45 -50 min with a success rate (beating hearts) of more than 90%. Rejection of heart graft was not associated with death of recipients. The graft function was evaluated by palpation of the abdominal wall daily after operation. The function of the donor heart was assessed using a subjective score of 0 to 3 described by Corry et al. (zero for no beating; 0.5 for very weak beating; one for weak beating; two for moderate beating; three for full beating).
Mice
All mice used in this study were maintained on the C57BL/6 genetic background. Tcrb -/-mice are genetically engineered immune deficient mice which lack T cell receptor beta chain [17] . DEE mice are transgenic mice that express ubiquitously LCMV-GP under the H-2k promoter [18] . Tcrb and DEE mice were used as heart transplant donor. As recipient, we used C57BL/6 mice and IL-10 -/-mice, which lack the production of the immunoregulatory cytokine IL-10 [19] . At least eight-weeks-old male mice were used as recipients for all studies. All animals were housed in single ventilated cages. During survival experiments, the health status of mice was checked twice daily. Animal experiments were authorized by the Nordrhein Westfalen Landesamt für Natur, Umwelt und Verbraucherschutz (Recklinghausen, Germany), and in accordance with the German and Canadian law for animal protection.
Virus and plaque assay LCMV strain WE was originally obtained from F. Lehmann-Grube (Heinrich Pette Institute, Hamburg, Germany) and was propagated in L929 cells. Tcrb -/-mice were infected intravenously with 2 x 10 6 PFU of LCMV-WE to generate carrier mice. For creation of memory mice, naïve C57BL/6 mice were infected intravenously with 200 PFU of LCMV strain WE. Viral titers were measured in a plaque forming assay using MC57 cells as previously described [20] .
CK-MB, Trop I, LDH and ALT
Biochemical analysis of creatinine-kinase MB (CK-MB), troponine I (Trop I), lactate dehydrogenase (LDH) and alanine transferase (ALT) were done in sera by the central laboratory, University Hospital Essen, Germany.
Flow cytometry
Tetramers were provided by the National Institute of Health (NIH) Tetramer Facility. In short, 20 μl of blood was stained with allophycocyanin (APC)-labeled GP33 MHC class I tetramers (GP33/H-2Db) for 15 minutes at 37°C. After incubation, the samples were stained with anti-CD8 peridinin-chlorophyllprotein-complex (PerCP; BD Biosciences, Franklin Lakes, NJ) for 30 minutes at 4°C. Erythrocytes were then lysed using 1ml BD lysing solution (BD Biosciences); cells were washed with FACS buffer and analyzed in flow cytometer. Absolute numbers of GP33-specific CD8 + T cells were calculated from FACS analysis using fluorescing beads (BD Biosciences). For intracellular interferon gamma (IFN)-γ staining, splenocytes or lymphocytes in blood were stimulated with GP33 in the presence of Brefeldin A. After 6 hours, cells were stained for CD8 for 30 minutes at 4°C, fixed with 2% Formaldehyde for 10 minutes and permeabilized with 1% Saponin solution, and stained for IFN-γ with anti-mouse IFN-γ antibody (eBioscience) and analyzed in flow cytometry.
IL-10 ELISA
Enzyme linked immunosorbent assay (ELISA) has been performed by the Mouse IL-10 ELISA Ready-SET-Go! ® reagent kit using 20 µl of plasma.
Histologic analysis
Histologic analysis of snap-frozen tissues were performed for immunohistochemistry with mouse monoclonal antibodies to LCMV nucleoprotein (made in house) and CD8 (BD Bioscience) and haematoxylin eosin staining (H&E).
Statistical analysis
If not differently stated data are expressed as means and S.E.M. Student's t-test was used to detect statistically significant differences between groups. Significant differences between several groups were detected by two-way analysis of variance (ANOVA). The level of statistical significance was set at * P < 0.05, ** P < 0.01 and *** P < 0.001.
Results
Transplantation of hearts after LCMV infection led to CD8+ T cell exhaustion and persistent viral infection
We analyzed how transfer of viral infected hearts influenced immune activation, viral control and syngeneic graft survival. Therefore, we generated lymphocytic choriomeningitis (Fig. 1A) . Transplanted mice, which were infected intravenously with LCMV, could clear the infection, whereas WT recipients receiving LCMV infected hearts could not control the transmitted viral infection (Fig. 1B) . Lack of viral control correlated with reduced numbers of LCMV specific CD8 + T cells (TET-GP33 + ) in mice receiving LCMV infected hearts (Fig. 1C) . IFN-γ production of CD8 + T cells was reduced on day 14 post-transplant in mice which received LCMV carrier heart transplantation (LCMV-HTX) (Fig. 1D) . Transplanted mice showed a transient reduction in the heart function assuming inflammation (Fig. 1E) . Indeed, creatinine kinase of muscle-brain type (CK-MB) was enhanced at day 9 post-transplant (Fig. 1F) . CK-MB is specific for myocardium and is used as major indicator for myocardial damage besides troponine I (Trop I) & T. Trop I was mildly elevated but it was not significant (Fig. 1F) . Histology revealed mild infiltration of lymphocytes in LCMV infected hearts (Fig. 1G) . Taken together, these data show that viral infected hearts activate virus specific CD8 + T cells, but with limited functionality resulting in viral persistence and survival of syngeneic heart grafts.
Presence of memory CD8+ T cells led to viral control but acute heart rejection after transplantation of LCMV infected hearts
Next, we investigated whether memory T cells could prevent viral persistence. Therefore, we induced memory CD8 + T cells in C57BL/6 mice by injecting 200 PFU of LCMV-WE intravenously. After priming with LCMV, mice generated a specific immune response which led to control of virus infection [21] . We transplanted LCMV carrier hearts into those memory mice ( Fig. 2A) . Transplantation of LCMV infected hearts led to massive CD8 + T cell expansion (Fig. 2B) . Memory CD8 + T cells got highly activated shown by down regulation of CD127, CD62L and PD-1 and high expression of CD44 on GP33 specific CD8 + T cells (Fig.  2C) . Virus specific CD8
+ T cells could control LCMV (Fig. 2D ) and transplanted hearts were rejected significantly earlier in memory mice (Fig. 2E ). In line with the acute heart rejection, heart specific parameters such as CK-MB and Trop I increased early after transplantation (Fig. 2F) . Histology revealed high numbers of infiltrating CD8 + T cells in the transplant (Fig.  1G ). In conclusion we found, that presence of memory CD8 + T cells resulted in early virus control, but led to fast rejection of viral infected hearts due to immunopathology.
Transplantation of LCMV infected hearts in absence of Interleukin-10 prevented T cell exhaustion and led to early death of mice
Next, we analyzed possible mechanism of CD8 + T cell exhaustion during transplantation of LCMV infected hearts. Interleukin-10 is known to play a crucial role for CD8 + T cell exhaustion during chronic infection [22] . Infection of LCMV-WE intravenously in IL-10 -/-mice led to accelerated and increased generation of LCMV specific CD8 + T cells compared to WT mice (Fig. 3A) .Transplantation of carrier hearts into IL-10 -/-mice (Fig. 3B ) resulted in higher amounts of CD8 + T cells (data not shown). Indeed, IL-10 was elevated in WT mice receiving LCMV infected heart transplant (Fig. 3C) . Virus load in blood was not affected by IL-10 (Fig. 3D) . IL-10 -/-mice rejected the hearts within 10 days (Fig. 3E ) and heart enzymes were elevated in IL-10 -/-mice (Fig. 3F ). In addition, IL-10 -/-mice recipients became ill and revealed high levels of lactate dehydrogenase (LDH) and alanine transferase (ALT) indicating a massive cell death in tissue and liver damage (Fig. 3G) . Mice revealed systemic illness and died between day 8 and 10 due to immunopathology (Fig. 3H ). Together these data show that IL-10 was essential to prevent syngeneic graft rejection after transplantation of infected hearts. 6 PFU of LCMV-WE intravenously (black filled rectangles) and WT mice received LCMV infected hearts (empty rectangles) at indicated days (n = 4). (E) Abdominal palpation of heart transplant is assessed by palpation scoring. Average palpation score is shown weekly after transplantation and infection (n = 4). (F) Levels of CK-MB and Trop I in sera of WT mice infected with 2 x 10 6 PFU of LCMV-WE intravenously and in sera of WT mice which received LCMV infected hearts at day 9 post-infection and post-transplant respectively (n = 4). (G) Representative H&E staining of hearts and representative immunofluorescence of hearts stained for LCMV nucleoprotein (green) and CD8 -/-mice, hearts were harvested between day 8 and 10 (n = 7; pooled from two experiments), in memory mice between day 6 and 8 (n = 4). In case of WT mice, transplanted hearts did not stop beating and were harvested at day 30 post-transplant. Scale bar, 100 μm and 50 μm. Data are shown as mean ± SEM. *P < 0.05; **P < 0.01 and ***P < 0.001 (Student's t-test) . 
Discussion
We mimicked the clinical situation of donor-derived viral infection in SOT in form of heterotopic syngeneic heart transplantation in a mouse model. This system allows us to focus on recipients' immune response against viral infection transmitted through organ transplantation. Still limitation of this model is the lack of mimicking fully or partially MHC mismatch in clinical situation.
Clinically, CMV is a major problem in SOT [23] . CMV is a herpesvirus which is widely spread in human beings. Seroprevalence of CMV varies between 30 and 97% in population [24, 25] . Consequently, more than 50% of solid organ transplant recipients suffer from CMV infection in the first 3 months post-transplant. Seropositivity of donor and recipient play a crucial role in morbidity and mortality for transplant recipient. CMV-seropositive donors and recipients are designated as D + and R + respectively. Subject to seroprevalence, different risk groups are categorized; for D + and R -(D + / R -) matching is the highest risk for CMV disease. The lowest risk for CMV disease is in case of seronegativity in donor and recipient (D -/R -) [26] . A CMV prophylaxis treatment is preserved for transplant recipients who are at highest risk for . Data are shown as mean ± SEM. *P < 0.05; **P < 0.01 and ***P < 0.001 (Student's t-test). Gassa 
. A retrospective study compared morbidity and mortality in four CMV donor/recipient serostatus categories [27] . As result, the group D + / R + showed the highest risk for mortality post-transplant, even though CMV disease occurs more often in D + / R -. In line with our data, recipients with memory T cells against the graft-transmitted virus show a strong immune response against syngeneic graft leading to rejection, whereas LCMV infection via transplant in naïve recipient mice led to chronic viral infection due to CD8
+ T cell exhaustion. The grafts survived and showed only partial dysfunction. -/-mice received LCMV carrier heart (n=7-15). Data are pooled from 2 or 3 independent experiments. Data are shown as mean ± SEM. *P < 0.05; **P < 0.01 and ***P < 0.001 (Student's t-test).
Another example for donor-derived infection is LCMV. LCMV is an arenavirus, which is very rare in human beings. An infection is usually asymptomatic in healthy persons and can be caused after close contact to house mice or hamsters [28, 29] . Some cases are known where LCMV was transmitted during transplantation. Donor-derived infection in several recipients led to death within three weeks after transplantation. The same strain could be detected in a cluster of patients, where seven of eight recipients died. The recipients revealed unspecific symptoms such as diarrhea, fever and systemic illness [30] . Normally, LCMV infection in non-immunosuppressed humans is asymptomatic.
Immunosuppression after transplantation aims to reduce immune response by the adaptive immune system. Nevertheless, it encloses many side effects such as a higher risk of opportunistic infections, an increased incidence of cancer and toxicity [31] .
A new perspective for tolerance in SOT is to understand CD8 + T cell exhaustion. T cell exhaustion is defined as a loss of effector function [32, 33] . Gradual loss can be distinguished in stages which are determined by diminished or vanished production of effector cytokines such as IFN-γ, increased expression of inhibitory cytokine receptors and deletion of antigenspecific T cells. Plus, T cell exhaustion correlates with viral persistence. Little is known in the field of transplantation medicine. We know that T cell exhaustion limits the immune response against chronic infections and tumors. In case of recrudescence of exhausted T cells, clearance of infections and tumors can be induced [34] .
Previous clinical studies effort to reactivate exhausted T cells as treatment for chronic infections or tumor disease [35] . However, the mechanisms leading to T cell exhaustion are unknown. Further, the role of T cell exhaustion in transplantation or autoimmunity is not defined. Recently, Sarraj et al. [36] showed that genetic depletion of selectin ligand for leucocyte migration led to impaired T cell function. They focused on CD4
+ T cells and induced T cell exhaustion in a murine transplantation model by impaired migration capability. They determined T cell exhaustion by impaired effector cytokine production (IFN-γ), defective proliferation of CD4 + T cells and higher PD-1 expression. Knock-out mice recipients providing impaired migration capability revealed T cell exhaustion and showed prolonged graft survival. T cells were not able to migrate in the MHC II mismatched heart transplant which in consequence led to permanent activation of T cells and then to T cell exhaustion. Graft survival was significantly increased. The data demonstrate that T cell exhaustion can lead to tolerance of syngeneic graft.
In line with that finding, IL-10 is an immunoregulatory cytokine that is associated with T cell exhaustion [37] . Its function during viral infection is described to be immunosuppressive by suppressing cytokine production and proliferation of CD8 + and CD4 + T cells leading to viral persistence [38] . A variety of cells can produce IL-10 such as T cells, B cells and antigenpresenting cells (APC) [37, 39, 40] . Clinical studies demonstrated that polymorphisms linked with increased IL-10 production are associated with increased susceptibility to chronic HCV infection and increased severity of chronic HBV infection [41] [42] [43] . Vice versa, polymorphisms with reduced expression of IL-10 correlate with a slower progression of AIDS in HIV-infected patients [44] . Its role in transplantation medicine is poorly understood. As IL-10 is known for its anti-inflammatory response and immunosuppressive role, it should abet graft survival.
Indeed, IL-10 inhibits ischemia/reperfusion injury [45] , extends syngeneic graft survival and function [46] [47] [48] and is essential for the action of regulatory T cells mediating tolerance at least in some transplant models [49] . In our model, IL-10 deficiency mice receiving LCMV loaded heart died early after transplantation. Loss of IL-10 in recipients showed a systemic immune response with immunopathology indicating that absence of IL-10 prevents T cell exhaustion. Its immunoregulatory function during viral infection through organ transplantation helps tolerating the syngeneic graft. In addition IL-10 may impact on regulatory cells, which can influence heart function [50] . This changed in case of memory mice. Memory CD8 + T cells were capable to control donor-derived LCMV infection but induced an acute graft rejection. Memory T cells play a major role in acute and chronic syngeneic graft rejection. Pre-transplant frequency of donor-specific alloreactive memory T cells in recipient correlates with the risk of long-term graft rejection [51] . Previous experimental
